Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was down 8.1% during mid-day trading on Wednesday . The stock traded as low as $6.34 and last traded at $6.37. Approximately 13,518 shares changed hands during mid-day trading, a decline of 23% from the average daily volume of 17,622 shares. The stock had previously closed at $6.93.
Fortress Biotech Stock Performance
The firm’s 50-day moving average price is $5.83 and its 200 day moving average price is $7.97.
Fortress Biotech Company Profile
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Read More
- Five stocks we like better than Fortress Biotech
- What is Short Interest? How to Use It
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Are Penny Stocks a Good Fit for Your Portfolio?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
